The role of microglia in brain maintenance: Implications for Rett syndrome

Trends in Immunology

Volumn 34, Issue 3, 2013, Pages 144-150

  Derecki, Noël C ^a   Cronk, James C ^a,b   Kipnis, Jonathan ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

BRAIN DEVELOPMENT; CELLULAR IMMUNITY; HOMEOSTASIS; HUMAN; IMMUNOREGULATION; MICROGLIA; NONHUMAN; PHAGOCYTOSIS; RETT SYNDROME; REVIEW; TISSUE REPAIR;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; HUMANS; METHYL-CPG-BINDING PROTEIN 2; MICE; MICE, KNOCKOUT; MICROGLIA; PHAGOCYTOSIS; RETT SYNDROME;

EID: 84875234176     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2012.10.002     Document Type: Review

References (103)

1. Rio-Hortega D. Cytology and Cellular Pathology of the Nervous System. Microglia 1932, P.B. Hoebaer, pp. 483-534.
2. Alliot F., et al. Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain. Brain Res. Dev. Brain Res. 1999, 117:145-152.
3. Ginhoux F., et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010, 330:841-845.
4. Schulz C., et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 2012, 336:86-90.
5. Cui Y., et al. Neuroprotective effect of methyl lucidone against microglia-mediated neurotoxicity. Eur. J. Pharmacol. 2012, 690:4-12.
6. Mead E.L., et al. Microglial neurotransmitter receptors trigger superoxide production in microglia; consequences for microglial-neuronal interactions. J. Neurochem. 2012, 121:287-301.
7. Filipov N.M., Dodd C.A. Role of glial cells in manganese neurotoxicity. J. Appl. Toxicol. 2012, 32:310-317.
8. Lull M.E., Block M.L. Microglial activation and chronic neurodegeneration. Neurotherapeutics 2010, 7:354-365.
9. Ajami B., et al. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat. Neurosci. 2007, 10:1538-1543.
10. Mildner A., et al. Distinct and non-redundant roles of microglia and myeloid subsets in mouse models of Alzheimer's disease. J. Neurosci. 2011, 31:11159-11171.
11. Mildner A., et al. Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nat. Neurosci. 2007, 10:1544-1553.
12. Nimmerjahn A., et al. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005, 308:1314-1318.
13. Hanisch U.K., Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 2007, 10:1387-1394.
14. Aloisi F., et al. Functional maturation of adult mouse resting microglia into an APC is promoted by granulocyte-macrophage colony-stimulating factor and interaction with Th1 cells. J. Immunol. 2000, 164:1705-1712.
15. Ravichandran K.S. Find-me and eat-me signals in apoptotic cell clearance: progress and conundrums. J. Exp. Med. 2010, 207:1807-1817.
16. Kinchen J.M., Ravichandran K.S. Identification of two evolutionarily conserved genes regulating processing of engulfed apoptotic cells. Nature 2010, 464:778-782.
17. Kinchen J.M., Ravichandran K.S. Phagocytic signaling: you can touch, but you can't eat. Curr. Biol. 2008, 18:R521-R524.
18. Roth K.A., D'Sa C. Apoptosis and brain development. Ment. Retard. Dev. Disabil. Res. Rev. 2001, 7:261-266.
19. Marin-Teva J.L., et al. Microglia promote the death of developing Purkinje cells. Neuron 2004, 41:535-547.
20. Wakselman S., et al. Developmental neuronal death in hippocampus requires the microglial CD11b integrin and DAP12 immunoreceptor. J. Neurosci. 2008, 28:8138-8143.
21. Sierra A., et al. Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis. Cell Stem Cell 2010, 7:483-495.
22. Paolicelli R.C., et al. Synaptic pruning by microglia is necessary for normal brain development. Science 2011, 333:1456-1458.
23. Tremblay M.E., et al. Microglial interactions with synapses are modulated by visual experience. PLoS Biol. 2010, 8:e1000527.
24. Schafer D.P., et al. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 2012, 74:691-705.
25. Stevens B., et al. The classical complement cascade mediates CNS synapse elimination. Cell 2007, 131:1164-1178.
26. Mehler M.F., Kessler J.A. Hematolymphopoietic and inflammatory cytokines in neural development. Trends Neurosci. 1997, 20:357-365.
27. Deverman B.E., Patterson P.H. Cytokines and CNS development. Neuron 2009, 64:61-78.
28. Golan H., et al. Involvement of tumor necrosis factor alpha in hippocampal development and function. Cereb. Cortex 2004, 14:97-105.
29. Zhong Y., et al. The direction of synaptic plasticity mediated by C-fibers in spinal dorsal horn is decided by Src-family kinases in microglia: the role of tumor necrosis factor-alpha. Brain Behav. Immun. 2010, 24:874-880.
30. Shi C., Pamer E.G. Monocyte recruitment during infection and inflammation. Nat. Rev. Immunol. 2011, 11:762-774.
31. Edwards J.P., et al. Biochemical and functional characterization of three activated macrophage populations. J. Leukoc. Biol. 2006, 80:1298-1307.
32. Mantovani A., et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004, 25:677-686.
33. Shechter R., et al. Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med. 2009, 6:e1000113.
34. Schwartz M. " Tissue-repairing" blood-derived macrophages are essential for healing of the injured spinal cord: from skin-activated macrophages to infiltrating blood-derived cells?. Brain Behav. Immun. 2010, 24:1054-1057.
35. Michelucci A., et al. Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: effects of oligomeric and fibrillar amyloid-beta. J. Neuroimmunol. 2009, 210:3-12.
36. Fadok V.A., et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 1998, 101:890-898.
37. Magnus T., et al. Microglial phagocytosis of apoptotic inflammatory T cells leads to down-regulation of microglial immune activation. J. Immunol. 2001, 167:5004-5010.
38. Neher J.J., et al. Inhibition of microglial phagocytosis is sufficient to prevent inflammatory neuronal death. J. Immunol. 2011, 186:4973-4983.
39. Fricker M., et al. MFG-E8 mediates primary phagocytosis of viable neurons during neuroinflammation. J. Neurosci. 2012, 32:2657-2666.
40. Neher J.J., et al. Inhibition of microglial phagocytosis is sufficient to prevent inflammatory neuronal death. J. Immunol. 2011, 186:4973-4983.
41. Fricker M., et al. Primary phagocytosis of viable neurons by microglia activated with LPS or Abeta is dependent on calreticulin/LRP phagocytic signalling. J. Neuroinflammation 2012, 9:196.
42. Bessis A., et al. Microglial control of neuronal death and synaptic properties. Glia 2007, 55:233-238.
43. Lazarini F., Lledo P.M. Is adult neurogenesis essential for olfaction?. Trends Neurosci. 2011, 34:20-30.
44. Glass C.K., et al. Mechanisms underlying inflammation in neurodegeneration. Cell 2010, 140:918-934.
45. Block M.L., et al. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 2007, 8:57-69.
46. Wu D.C., et al. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J. Neurosci. 2002, 22:1763-1771.
47. D'Aversa T.G., et al. Expression of chemokines by human fetal microglia after treatment with the human immunodeficiency virus type 1 protein Tat. J. Neurovirol. 2004, 10:86-97.
48. Block M.L., et al. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 2007, 8:57-69.
49. Cardona A.E., et al. Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 2006, 9:917-924.
50. El Khoury J., et al. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat. Med. 2007, 13:432-438.
51. Butovsky O., et al. Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis. J. Clin. Invest. 2006, 116:905-915.
52. Persson M., et al. Lipopolysaccharide increases microglial GLT-1 expression and glutamate uptake capacity in vitro by a mechanism dependent on TNF-alpha. Glia 2005, 51:111-120.
53. Neumann J., et al. Microglia provide neuroprotection after ischemia. FASEB J. 2006, 20:714-716.
54. Vinet J., et al. Neuroprotective function for ramified microglia in hippocampal excitotoxicity. J. Neuroinflammation 2012, 9:27.
55. Lassmann H., et al. Microglial cells are a component of the perivascular glia limitans. J. Neurosci. Res. 1991, 28:236-243.
56. Butovsky O., et al. Microglia activated by IL-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Mol. Cell. Neurosci. 2005, 31:149-160.
57. Dluzniewska J., et al. A strong neuroprotective effect of the autonomous C-terminal peptide of IGF-1 Ec (MGF) in brain ischemia. FASEB J. 2005, 19:1896-1898.
58. Kaspar B.K., et al. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 2003, 301:839-842.
59. Ebert A.D., et al. Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson's disease. Exp. Neurol. 2008, 209:213-223.
60. Ponomarev E.D., et al. MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-alpha-PU.1 pathway. Nat. Med. 2011, 17:64-70.
61. Ladeby R., et al. Microglial cell population dynamics in the injured adult central nervous system. Brain Res. Brain Res. Rev. 2005, 48:196-206.
62. Flugel A., et al. Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity 2001, 14:547-560.
63. Hanisch U.K., Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 2007, 10:1387-1394.
64. Kobayashi T., et al. The Twitcher mouse: an enzymatically authentic model of human globoid cell leukodystrophy (Krabbe disease). Brain Res. 1980, 202:479-483.
65. Kohlschutter A., Eichler F. Childhood leukodystrophies: a clinical perspective. Expert Rev. Neurother. 2011, 11:1485-1496.
66. Hoogerbrugge P.M., et al. Donor-derived cells in the central nervous system of twitcher mice after bone marrow transplantation. Science 1988, 239:1035-1038.
67. Suzuki K. Globoid cell leukodystrophy (Krabbe's disease): update. J. Child Neurol. 2003, 18:595-603.
68. Krivit W. Stem cell bone marrow transplantation in patients with metabolic storage diseases. Adv. Pediatr. 2002, 49:359-378.
69. Amir R.E., et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 1999, 23:185-188.
70. Chahrour M., et al. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 2008, 320:1224-1229.
71. Shetty A.K., et al. Syndrome of microcephaly, mental retardation, and tracheoesophageal fistula associated with features of Rett syndrome. J. Child Neurol. 2000, 15:61-63.
72. Armstrong D.D. Neuropathology of Rett syndrome. J. Child Neurol. 2005, 20:747-753.
73. Noutel J., et al. Experience-dependent retinogeniculate synapse remodeling is abnormal in MeCP2-deficient mice. Neuron 2011, 70:35-42.
74. Tong Y., et al. T-bet antagonizes mSin3a recruitment and transactivates a fully methylated IFN-gamma promoter via a conserved T-box half-site. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:2034-2039.
75. Lal G., et al. Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation. J. Immunol. 2009, 182:259-273.
76. Balmer D., et al. MECP2 mutations in Rett syndrome adversely affect lymphocyte growth, but do not affect imprinted gene expression in blood or brain. Hum. Genet. 2002, 110:545-552.
77. Maezawa I., et al. Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions. J. Neurosci. 2009, 29:5051-5061.
78. Ballas N., et al. Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology. Nat. Neurosci. 2009, 12:311-317.
79. Alvarez-Saavedra M., et al. Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis. Hum. Mol. Genet. 2007, 16:2315-2325.
80. Guy J., et al. Reversal of neurological defects in a mouse model of Rett syndrome. Science 2007, 315:1143-1147.
81. Lioy D.T., et al. A role for glia in the progression of Rett's syndrome. Nature 2011, 475:497-500.
82. Maezawa I., Jin L.W. Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate. J. Neurosci. 2010, 30:5346-5356.
83. Derecki N.C., et al. Wild-type microglia arrest pathology in a mouse model of Rett syndrome. Nature 2012, 484:105-109.
84. Koizumi S., et al. UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis. Nature 2007, 446:1091-1095.
85. Takahashi K., et al. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J. Exp. Med. 2005, 201:647-657.
86. Paloneva J., et al. Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. Am. J. Hum. Genet. 2002, 71:656-662.
87. Hofstaetter J.G., et al. Altered bone matrix mineralization in a patient with Rett syndrome. Bone 2010, 47:701-705.
88. Han Z.A., et al. Clinical characteristics of children with rett syndrome. Ann. Rehabil. Med. 2012, 36:334-339.
89. Rastegar M., et al. MECP2 isoform-specific vectors with regulated expression for Rett syndrome gene therapy. PLoS ONE 2009, 4:e6810.
90. Jugloff D.G., et al. Targeted delivery of an Mecp2 transgene to forebrain neurons improves the behavior of female Mecp2-deficient mice. Hum. Mol. Genet. 2008, 17:1386-1396.
91. Tropea D., et al. Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:2029-2034.
92. Deogracias R., et al. Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:14230-14235.
93. Laflamme N., et al. Circulating cell wall components derived from gram-negative, not gram-positive, bacteria cause a profound induction of the gene-encoding Toll-like receptor 2 in the CNS. J. Neurochem. 2001, 79:648-657.
94. Derecki N.C., et al. Regulation of learning and memory by meningeal immunity: a key role for IL-4. J. Exp. Med. 2010, 207:1067-1080.
95. Huh G.S., et al. Functional requirement for class I MHC in CNS development and plasticity. Science 2000, 290:2155-2159.
96. Hamza T.H., et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat. Genet. 2010, 42:781-785.
97. Oddo S., et al. Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron 2004, 43:321-332.
98. Kwan W., et al. Bone marrow transplantation confers modest benefits in mouse models of Huntington's disease. J. Neurosci. 2012, 32:133-142.
99. Dantzer R., et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-56.
100. Kipnis J., et al. Loss of autoimmune T cells correlates with brain diseases: possible implications for schizophrenia?. Trends Mol. Med. 2006, 12:107-112.
101. Kaminsky Z., et al. A multi-tissue analysis identifies HLA complex group 9 gene methylation differences in bipolar disorder. Mol. Psychiatry 2011, 17:728-740.
102. Ziv Y., et al. Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat. Neurosci. 2006, 9:268-275.
103. Kipnis J., et al. Pro-cognitive properties of T cells. Nature Rev. Immunol. 2012, 12:663-669.